Sleep health is not equal among US adults, with new research implicating education level, age, body mass index (BMI), and ...
The FDA announced Friday that it intends to restrict the active pharmaceutical ingredients of glucagon-like peptide-1 (GLP-1) ...
A new study published in the Journal of Neuroimmunology1 indicates that disease severity of muscle-specific kinase (MuSK) myasthenia gravis (MG) could be linked to MuSK antibody levels. The ...
An fresh look at trial results that propelled the only FDA approval of a chimeric antigen receptor (CAR) T-cell therapy for mantle cell lymphoma (MCL) shows prior treatment with ibrutinib, a ...
Adults living with idiopathic hypersomnia and narcolepsy type 1 often report cognitive difficulties, including problems with memory, attention, and mental fatigue. However, new research published in ...
The Gulliver-Gestalt-Psoriasis Area Severity Estimate (G2-PASE) was developed to address a longstanding challenge in ...
PBM reforms, Medicare Advantage trends, TrumpRx launch, and Express Scripts settlement highlight key shifts in drug pricing, ...
Vishal A. Patel, MD, explains that delayed skin cancer diagnoses contribute to more advanced disease and poorer outcomes in ...
Combined employer premium contributions and deductibles exceeded 10% of median household income in 19 states, ...
Importantly, several studies evaluated CBT-I as an adjunct to usual care for comorbid mental health conditions such as ...
The 2026 International Stroke Conference (ISC), held February 4-6 in New Orleans, Louisiana, delivered potentially ...
A new study links telomere length genetics to IPF risk, showing how rare variants and polygenic scores may guide future screening and precision care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results